Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Biogen Pharmachem Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 531752

₹0.28

₹0.00 (0.00%)

As on 04-Sep-2026IST

Market cap

info icon

₹29 Cr

Revenue (TTM)

info icon

₹1 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -23.36 -71.29 -64.73 11.18 -21.25
EBIT 161.56 -83.57 -136.88 -299.45 -196.98
Net Profit 161.56 -83.57 -64.73 11.18 -21.25
EPS 161.76 -83.59 -114.41 -136.76 13.85
Book Value -- -- -0.53 1.27 0.17
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info ---49.71-59.06----
Net Margin info ---0.35-11.39----
Return on equity info 1.260.17-0.17-0.523.48
Return on Capital info 1.320.20---0.363.48
Return on Assets info 1.300.19-0.17-0.393.46
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
-0.36
3.48
0.84
-0.02
Peer Median
--
3.50
10.64
0.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-0.17

Lower than Peers by 15.00

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-0.17
-0.52
3.48
0.84
-0.02
Peer Median
14.83
1.79
26.31
0.65
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-0.17

Lower than Peers by 5.73

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-0.17
-0.39
3.46
0.83
-0.02
Peer Median
5.55
1.68
2.48
0.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-59.06

Lower than Peers by 94.99

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-59.06
--
--
--
-0.61
Peer Median
35.93
37.67
54.90
27.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-11.39

Lower than Peers by 24.46

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-11.39
-24.44
81.07
49.90
-0.35
Peer Median
13.08
15.34
15.32
22.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
-0.35
Peer Median
0.00
--
--
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-64.73

Lower than Peers by 86.32

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-64.73
--
--
-100.00
52.48
Peer Median
21.59
48.89
42.20
46.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-136.88

Lower than Peers by 159.43

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-136.88
-225.55
1.40
-2,907.89
99.05
Peer Median
22.55
11.00
51.15
16.35
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-64.73

Lower than Peers by 81.74

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-64.73
-115.16
323.86
5,396.51
99.46
Peer Median
17.01
-21.65
36.20
63.86
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-114.41

Lower than Peers by 125.25

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-114.41
-115.20
322.86
7,100.00
99.59
Peer Median
10.83
-21.88
36.23
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
-0.52
3.54
0.84
-0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
0.01
1.40
0.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.28

Higher than Peers by 0.06

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
2.28
29.65
0.30
0.65
2.37
Peer Median
2.21
3.35
1.02
3.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.28

Higher than Peers by 0.13

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
2.28
29.65
0.30
0.65
2.37
Peer Median
2.14
3.66
5.14
4.69
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
4,556.00
-42.00
Peer Median
20.17
7.04
1.66
4.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
5.98
31.95
18.14
32.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

Lower than Peers by 0.28

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
0.01
--
--
--
0.05
Peer Median
0.29
0.15
0.63
0.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

-127.97

Lower than Peers by 159.10

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-127.97
--
35.81
84.29
--
Peer Median
31.13
80.10
52.43
85.70
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.26

Lower than Peers by 3.53

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
0.26
1.11
1.22
0.71
1.69
Peer Median
3.79
1.44
11.30
0.98
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
--
--
--
--
--
Peer Median
0.08
--
0.04
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-175.68

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
-175.68
-224.65
35.82
84.23
--
Peer Median
--
5.87
13.03
1.34
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

29

Lower than Peers by 1,07,901

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Biogen Pharmachem
29
--
--
--
91
Peer Median
1,07,931
18
12,900
9
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...